255 related articles for article (PubMed ID: 16569256)
1. Most recent developments in strategies to reduce the progression of structural changes in osteoarthritis: today and tomorrow.
Pelletier JP; Martel-Pelletier J; Raynauld JP
Arthritis Res Ther; 2006; 8(2):206. PubMed ID: 16569256
[TBL] [Abstract][Full Text] [Related]
2. Osteoarthritis research priorities: a report from a EULAR ad hoc expert committee.
Conaghan PG; Kloppenburg M; Schett G; Bijlsma JW;
Ann Rheum Dis; 2014 Aug; 73(8):1442-5. PubMed ID: 24625626
[TBL] [Abstract][Full Text] [Related]
3. DMOAD developments: present and future.
Pelletier JP; Martel-Pelletier J
Bull NYU Hosp Jt Dis; 2007; 65(3):242-8. PubMed ID: 17922676
[TBL] [Abstract][Full Text] [Related]
4. Emerging pathways and promising agents with possible disease modifying effect in osteoarthritis treatment.
Jotanovic Z; Mihelic R; Sestan B; Dembic Z
Curr Drug Targets; 2014 Jun; 15(6):635-61. PubMed ID: 24597569
[TBL] [Abstract][Full Text] [Related]
5. New horizons in osteoarthritis.
Oliviero F; Ramonda R; Punzi L
Swiss Med Wkly; 2010; 140():w13098. PubMed ID: 20458653
[TBL] [Abstract][Full Text] [Related]
6. Rationale for the use of structure-modifying drugs and agents in the treatment of osteoarthritis.
Pelletier JP
Osteoarthritis Cartilage; 2004; 12 Suppl A():S63-8. PubMed ID: 14698646
[TBL] [Abstract][Full Text] [Related]
7. The management of osteoarthritis in the third millennium.
Dieppe P
Scand J Rheumatol; 2000; 29(5):279-81. PubMed ID: 11093592
[TBL] [Abstract][Full Text] [Related]
8. Hydroxychloroquine in patients with inflammatory and erosive osteoarthritis of the hands (OA TREAT): study protocol for a randomized controlled trial.
Detert J; Klaus P; Listing J; Höhne-Zimmer V; Braun T; Wassenberg S; Rau R; Buttgereit F; Burmester GR
Trials; 2014 Oct; 15():412. PubMed ID: 25348033
[TBL] [Abstract][Full Text] [Related]
9. OA clinical trials: current targets and trials for OA. Choosing molecular targets: what have we learned and where we are headed?
Hellio Le Graverand-Gastineau MP
Osteoarthritis Cartilage; 2009 Nov; 17(11):1393-401. PubMed ID: 19426849
[TBL] [Abstract][Full Text] [Related]
10. Developing strategic priorities in osteoarthritis research: Proceedings and recommendations arising from the 2017 Australian Osteoarthritis Summit.
Hunter DJ; Nicolson PJA; Little CB; Robbins SR; Wang X; Bennell KL
BMC Musculoskelet Disord; 2019 Feb; 20(1):74. PubMed ID: 30760253
[TBL] [Abstract][Full Text] [Related]
11. Pharmacologic therapy for osteoarthritis--the era of disease modification.
Hunter DJ
Nat Rev Rheumatol; 2011 Jan; 7(1):13-22. PubMed ID: 21079644
[TBL] [Abstract][Full Text] [Related]
12. Neuropathic pain in osteoarthritis: a review of pathophysiological mechanisms and implications for treatment.
Dimitroulas T; Duarte RV; Behura A; Kitas GD; Raphael JH
Semin Arthritis Rheum; 2014 Oct; 44(2):145-54. PubMed ID: 24928208
[TBL] [Abstract][Full Text] [Related]
13. Disease modification: promising targets and impediments to success.
Matthews GL
Rheum Dis Clin North Am; 2013 Feb; 39(1):177-87. PubMed ID: 23312415
[TBL] [Abstract][Full Text] [Related]
14. New and emerging treatments for osteoarthritis management: will the dream come true with personalized medicine?
Roubille C; Pelletier JP; Martel-Pelletier J
Expert Opin Pharmacother; 2013 Oct; 14(15):2059-77. PubMed ID: 24044485
[TBL] [Abstract][Full Text] [Related]
15. Pharmacogenetics/pharmacogenomics and antirheumatic drugs in rheumatology.
Ferraccioli G; De Santis M; Tolusso B
Pharmacogenomics; 2004 Dec; 5(8):1107-16. PubMed ID: 15584877
[TBL] [Abstract][Full Text] [Related]
16. The role of cytokines in osteoarthritis pathophysiology.
Fernandes JC; Martel-Pelletier J; Pelletier JP
Biorheology; 2002; 39(1-2):237-46. PubMed ID: 12082286
[TBL] [Abstract][Full Text] [Related]
17. Classification of osteoarthritis biomarkers: a proposed approach.
Bauer DC; Hunter DJ; Abramson SB; Attur M; Corr M; Felson D; Heinegård D; Jordan JM; Kepler TB; Lane NE; Saxne T; Tyree B; Kraus VB;
Osteoarthritis Cartilage; 2006 Aug; 14(8):723-7. PubMed ID: 16733093
[TBL] [Abstract][Full Text] [Related]
18. Early management of osteoarthritis.
Altman RD
Am J Manag Care; 2010 Mar; 16 Suppl Management():S41-7. PubMed ID: 20297876
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in osteoarthritis.
Lim KK; Shahid M; Sharif M
Singapore Med J; 1996 Apr; 37(2):189-93. PubMed ID: 8942262
[TBL] [Abstract][Full Text] [Related]
20. Inflammation (or synovitis)-driven osteoarthritis: an opportunity for personalizing prognosis and treatment?
Siebuhr AS; Bay-Jensen AC; Jordan JM; Kjelgaard-Petersen CF; Christiansen C; Abramson SB; Attur M; Berenbaum F; Kraus V; Karsdal MA
Scand J Rheumatol; 2016; 45(2):87-98. PubMed ID: 26484849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
